arrow
A

Ali F. Altebainawi

pharmaceutical care services, king salman specialist hospital, hail health cluster, ministry of health, hail, saudi arabia
H指数:11
被引数:506

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evaluation of the Impact of Statin Therapy Intensity on the Risk of Delirium in Critically Ill Patients Admitted to ICUs: A Multicenter Cohort Study

评估ICU收治的重症患者中他汀类药物疗法强度对谵妄风险的影响:一项多中心队列研究

2025-09-110
PRE
Evaluation of Effectiveness and Safety of Dexmedetomidine in non-Mechanically Ventilated COVID-19 Critically ill Patients: A Multicentre Cohort Study

评价右美托咪定在新型冠状病毒肺炎危重患者非机械通气中的有效性和安全性: 一项多中心队列研究

2024-11-180
PRE
Ketamine-based Sedation Use in Mechanically Ventilated Critically Ill Patients with COVID-19: A Multicenter Cohort Study
2024-05-010
OAAI
Dexamethasone versus methylprednisolone for multiple organ dysfunction in COVID-19 critically ill patients: a multicenter propensity score matching study
2024-02-131
OAAI
The association between tocilizumab therapy and the development of thrombosis in critically ill patients with COVID-19: a multicenter, cohort study
2024-02-063
OAAI
The use of Tocilizumab in COVID-19 critically ill patients with renal impairment: a multicenter, cohort study
2023-10-232
OAAI
Survival implications vs. complications: unraveling the impact of vitamin D adjunctive use in critically ill patients with COVID-19-A multicenter cohort study
2023-08-241
OAAI
The effect of oseltamivir use in critically ill patients with COVID-19: A multicenter propensity score-matched study
2023-07-012
OAAI
The clinical outcomes of COVID-19 critically ill patients co-infected with other respiratory viruses: a multicenter, cohort study (vol 23, 75, 2023)
2023-02-222
OAAI
The clinical outcomes of COVID-19 critically ill patients co-infected with other respiratory viruses: a multicenter, cohort study
2023-02-066
OAAI
Evaluation of Early Tocilizumab Effect on Multiorgan Dysfunction in Critically Ill Patients With COVID-19: A Propensity Score-Matched Study
2023-01-221
OA
Health economic burden of COVID-19 in Saudi Arabia

沙特阿拉伯新型冠状病毒肺炎的健康经济负担

2022-10-204
OAAI
Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study
2022-10-0329
OAAI
The impact of HMG-CoA reductase inhibitors use on the clinical outcomes in critically ill patients with COVID-19: A multicenter, cohort study
2022-08-117
OAAI
Early dexamethasone use as a protective measure in non-mechanically ventilated critically ill patients with COVID-19: a multicenter, cohort study
2022-06-133
OAAI
Evaluation of Low-Dose Aspirin use among Critically Ill Patients with COVID-19: A Multicenter Propensity Score Matched Study
2022-04-216
OA
The Role of Inhaled Corticosteroids (ICS) in Critically Ill Patients With COVID-19: A Multicenter, Cohort Study

吸入糖皮质激素 (ICS) 在重症新型冠状病毒肺炎患者中的作用: 一项多中心队列研究

2021-11-109
OA